NVLG.TA Stock — Price, Charts & Analysis
Novolog Stock Fundamentals & Technical Report
Novolog (NVLG.TA) is reviewed here as a complete stock research report for the Tel Aviv market, bringing the core signals into one place: today's price action, valuation, earnings power, balance-sheet quality, cash flow, dividends, ownership, analyst expectations, RSI, support, resistance, moving averages, and technical momentum. The report is built from the data available on Worldtickers and keeps the company name front and center while preserving the ticker for quick market lookup.
Novolog Fundamental Analysis
Novolog Valuation Snapshot
What is the P/E ratio of Novolog (Pharm-Up 1966) Ltd?
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) has a trailing P/E of 73.20x. This places NVLG.TA in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.
Is Novolog (Pharm-Up 1966) Ltd overvalued or undervalued?
NVLG.TA trades with 73.20x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether NVLG.TA looks overvalued or undervalued.
What is a good P/E ratio for Novolog (Pharm-Up 1966) Ltd?
NVLG.TA's P/E of 73.20x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.
What is the EPS of Novolog (Pharm-Up 1966) Ltd?
NVLG.TA's trailing EPS is ILA 0.01. Reported earnings growth is -56.40%, which helps show current profit momentum.
What does EPS mean for Novolog (Pharm-Up 1966) Ltd investors?
EPS, or earnings per share, shows how much profit Novolog (Pharm-Up 1966) Ltd generated for each share. NVLG.TA's trailing EPS is ILA 0.01, and investors usually prefer EPS that is positive and growing over time.
What is the market cap of Novolog (Pharm-Up 1966) Ltd?
Novolog (Pharm-Up 1966) Ltd has a market cap of ILA 373.96M, making NVLG.TA a small-cap stock based on the current market value shown on Worldtickers.
What is Novolog (Pharm-Up 1966) Ltd's stock price today?
NVLG.TA's latest stock price on Worldtickers is ILA 73.20. The latest move is -ILA 1.00 or -1.35%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.
What is Novolog (Pharm-Up 1966) Ltd's stock quote?
NVLG.TA's quote includes a latest price of ILA 73.20. The market open is ILA 74.50. Previous close is ILA 74.20. The intraday range is ILA 73.10 to ILA 76.90.
Why is Novolog (Pharm-Up 1966) Ltd stock up or down today?
NVLG.TA is down in the latest quote, with a move of -ILA 1.00 or -1.35%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.
Novolog Business Fundamentals
What is Novolog (Pharm-Up 1966) Ltd's revenue?
NVLG.TA generated ILA 1.80B in trailing revenue. Revenue growth is -0.20%, which helps show whether demand is expanding or slowing.
How fast is Novolog (Pharm-Up 1966) Ltd's revenue growing?
NVLG.TA's revenue growth is -0.20%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.
Is Novolog (Pharm-Up 1966) Ltd profitable?
Yes, NVLG.TA shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is ILA 3.55M.
What is Novolog (Pharm-Up 1966) Ltd's profit margin?
Gross margin is 8.61%. Margins show how efficiently Novolog (Pharm-Up 1966) Ltd turns revenue into profit.
What is Novolog (Pharm-Up 1966) Ltd's debt?
Novolog (Pharm-Up 1966) Ltd carries ILA 176.20M and holds ILA 163.20M in cash.
Does Novolog (Pharm-Up 1966) Ltd have enough cash?
NVLG.TA holds ILA 163.20M on its balance sheet.
What is Novolog (Pharm-Up 1966) Ltd's book value?
NVLG.TA's book value per share is ILA 0.70.
Novolog Income & Dividends
Does Novolog (Pharm-Up 1966) Ltd pay a dividend?
Yes, Novolog (Pharm-Up 1966) Ltd pays a dividend of ILA 0.04 per share annually. The dividend yield is 528.00%. The payout ratio is 559.27%.
Is Novolog (Pharm-Up 1966) Ltd a good dividend stock?
NVLG.TA's dividend yield is 528.00%. Its payout ratio is 559.27%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.
When is Novolog (Pharm-Up 1966) Ltd's next dividend date?
Worldtickers does not currently show a confirmed next ex-dividend date for NVLG.TA. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Novolog (Pharm-Up 1966) Ltd's investor relations materials.
What is Novolog (Pharm-Up 1966) Ltd's dividend history?
NVLG.TA's five-year average dividend yield is 280.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.
Novolog Ownership Signals
Who owns Novolog (Pharm-Up 1966) Ltd stock?
Institutions hold 35.36% of NVLG.TA shares. Insiders hold 53.50% of shares. Ownership mix helps investors understand how much of Novolog (Pharm-Up 1966) Ltd is held by professional investors and company insiders.
How many shares of Novolog (Pharm-Up 1966) Ltd are outstanding?
NVLG.TA has 510.87M shares outstanding. Float shares are 330.48M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.
Should I follow Novolog (Pharm-Up 1966) Ltd insider trades?
Insider activity can be useful context for NVLG.TA, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.
Novolog Earnings Outlook
What to expect from Novolog (Pharm-Up 1966) Ltd earnings?
Earnings growth is -56.40%. Revenue growth is -0.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.
What is Novolog (Pharm-Up 1966) Ltd's earnings history?
NVLG.TA's trailing EPS is ILA 0.01. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.
Novolog Investment View
Is Novolog (Pharm-Up 1966) Ltd better than Healthcare average?
NVLG.TA is in the Healthcare sector. Its earnings multiple is 73.20x. Its latest displayed growth metric is -0.20%. Compare these figures with sector peers before deciding whether Novolog (Pharm-Up 1966) Ltd is stronger or weaker than average.
Should I invest in Novolog (Pharm-Up 1966) Ltd now?
NVLG.TA trades at ILA 73.20. The stock trades at 73.20x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Novolog (Pharm-Up 1966) Ltd's fundamentals.
What are the risks of buying Novolog (Pharm-Up 1966) Ltd?
NVLG.TA risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.14, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.
How does Novolog (Pharm-Up 1966) Ltd compare to its competitors?
NVLG.TA should be compared with companies in Medical Distribution. Its earnings multiple is 73.20x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.
Novolog Company Profile
What does Novolog (Pharm-Up 1966) Ltd do?
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) operates in Healthcare, specifically Medical Distribution. Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and dia
What exchange does Novolog (Pharm-Up 1966) Ltd trade on?
NVLG.TA trades on Tel Aviv. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.
What currency is Novolog (Pharm-Up 1966) Ltd stock priced in?
NVLG.TA stock is priced in ILA on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.
What is Novolog (Pharm-Up 1966) Ltd's official website?
Novolog (Pharm-Up 1966) Ltd's official website listed on Worldtickers is www.novolog.co.il. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.
How many employees does Novolog (Pharm-Up 1966) Ltd have?
Novolog (Pharm-Up 1966) Ltd employs about 916 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.
Where is Novolog (Pharm-Up 1966) Ltd headquartered?
Novolog (Pharm-Up 1966) Ltd is headquartered in Modi'in-Maccabim-Re'ut, Israel. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.
What sector is Novolog (Pharm-Up 1966) Ltd in?
NVLG.TA is in the Healthcare sector and the Medical Distribution industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.
Novolog Technical Analysis
What is Novolog (Pharm-Up 1966) Ltd's 52-week high and low?
NVLG.TA has traded between ILA 66.30 and ILA 157.00 over the past 52 weeks. At ILA 73.20, it is 53.38% below the high and 10.41% above the low. The 52-week range helps gauge long-term price momentum.
Is Novolog (Pharm-Up 1966) Ltd in an uptrend or downtrend?
NVLG.TA is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is ILA 75.59 and its 200-day moving average is ILA 104.22.
What is Novolog (Pharm-Up 1966) Ltd's RSI?
NVLG.TA's RSI is 44.01. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.
What is Novolog (Pharm-Up 1966) Ltd's RSI today?
NVLG.TA's latest RSI reading is 44.01, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.
What are Novolog (Pharm-Up 1966) Ltd's support and resistance levels?
Key support for NVLG.TA is near ILA 67.10. Key resistance is near ILA 90.00. Breaks above resistance or below support can change the short-term technical setup.
What is the support level for Novolog (Pharm-Up 1966) Ltd?
NVLG.TA's nearest reported support level is ILA 67.10. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.
What is the resistance level for Novolog (Pharm-Up 1966) Ltd?
NVLG.TA's nearest reported resistance level is ILA 90.00. A breakout above resistance can improve momentum, especially when volume confirms the move.
What is Novolog (Pharm-Up 1966) Ltd's average daily volume?
NVLG.TA trades about 422.93K shares daily on average. The latest displayed volume is 189.35K shares. Volume helps show liquidity and whether trading interest is unusually high or low.
What is Novolog (Pharm-Up 1966) Ltd's MACD?
NVLG.TA's MACD is -0.39, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.
Should I buy Novolog (Pharm-Up 1966) Ltd based on technical analysis?
NVLG.TA is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 44.01 (neutral). MACD is bearish. Nearest support is around ILA 67.10. Resistance is around ILA 90.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.
Where is Novolog (Pharm-Up 1966) Ltd versus its 20-day, 50-day, and 200-day moving averages?
MA20 is ILA 76.78 (-3.36% from price). MA50 is ILA 75.59 (-1.84% from price). MA200 is ILA 104.22 (-28.81% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.
What is Novolog (Pharm-Up 1966) Ltd's EMA signal?
The server report currently confirms daily moving-average levels rather than a separate EMA-only value. NVLG.TA's MA20 is ILA 76.78. MA50 is ILA 75.59. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.
What are Novolog (Pharm-Up 1966) Ltd's pivot, support, and resistance levels?
NVLG.TA's pivot is near ILA 76.57. Support is near ILA 67.10. Resistance is near ILA 90.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.
What are the next support and resistance zones for Novolog (Pharm-Up 1966) Ltd?
The next lower support zone for NVLG.TA is near ILA 66.83. The next upper resistance zone is near ILA 80.28. These levels help define risk and possible follow-through zones after a breakout or breakdown.
What do Bollinger Bands show for Novolog (Pharm-Up 1966) Ltd?
NVLG.TA's Bollinger range is roughly ILA 66.33 to ILA 87.23. Band width is near 27.23%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.
What is Novolog (Pharm-Up 1966) Ltd's ATR volatility?
NVLG.TA's ATR-based typical daily range is about 5.53%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.
Does volume confirm Novolog (Pharm-Up 1966) Ltd's move?
Latest volume is 189.35K shares. Average volume is about 422.93K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.
What is Novolog (Pharm-Up 1966) Ltd's all-time high and low?
NVLG.TA's all-time high shown on Worldtickers is ILA 369.20. Its all-time low is ILA 66.30. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.
What is Novolog (Pharm-Up 1966) Ltd's beta?
NVLG.TA has a beta of 0.14, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.
AI Market Desk
Free plan